Stanley Hsia to Hypoglycemia
This is a "connection" page, showing publications Stanley Hsia has written about Hypoglycemia.
Connection Strength
0.265
-
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study. Lancet. 2023 08 05; 402(10400):472-483.
Score: 0.206
-
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes. N Engl J Med. 2025 Sep 18; 393(11):1065-1076.
Score: 0.059